DIVISLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > divislab

Technical Analysis

Technical Strength: 5.75 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 56.3. According to RSI analysis, divislab is technically strong. 9.0 DIVISLAB RSI Chart
MACD (?) MACD: 68.2 and Signal Line: 87.2. According to MACD analysis, divislab is marginally weak. 3.0 DIVISLAB MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, divislab is in a strong uptrend. Major support levels are 3212.27, 2926.023, 2319.932. 6.0 DIVISLAB Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, divislab is in a strong uptrend. Major support levels are 3179.644, 2973.904, 2419.765. 6.0 DIVISLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.596. 5.0 DIVISLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA DIVISLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 119 NA DIVISLAB Average True Range Chart
Average Directional Index (?) ADX is 25.8 which means DIVISLAB is in a trend. NA DIVISLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
September 22, 2020
Open Price 3160.0
High Price 3273.8
Low Price 3042.55
Close Price 3236.6
Absolute Change 77.8
Percentage Change 2.46%
Weekly Change 1.62%
Monthly Change -0.287%
Yearly Change 100%
52-week high 3389.0
52-week low 1570.5
Corporate Actions
ExDate Purpose
September 04, 2020 ANNUAL GENERAL MEETING
February 25, 2020 INT DIV-RS 16 PER SH
August 14, 2019 AGM/DIV- RS 16 PER SH
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.588
Confidence in Beta3.41%
Market Capital Rs. 85921.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 41.73
TTM Price-to-Earnings (P/E) Ratio 77.6
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 22 September 2020: Deliverable Quantity:2.1e+05 NA DIVISLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 22 September 2020: Daily Volatility:0.4318 NA DIVISLAB Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 22 September 2020: PCR_OI:0.469 PCR:0.262 NA DIVISLAB PCR Chart
Option Pain (?) 22 September 2020: Max Pain:3240.0 NA DIVISLAB Option Pain Chart
Premium (?) 22 September 2020 Premium: 5.95 Futures OI:1543600.0 NA DIVISLAB Premium Chart
Option_MAX_OI (?) 22 September 2020: Price:3236.6 Put with maximum OI:3100.0 Call with maximum OI:3400.0 NA DIVISLAB Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
September 24, 2020 3242.55 1543600.0 9283.0 9283.0 3236.6
October 29, 2020 3256.25 1872800.0 5152.0 5152.0 3236.6
November 26, 2020 3280.0 12800.0 22.0 22.0 3236.6

Announcements

August 18, 2020 Book Closure Divi's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 08-Sep-2020 to 14-Sep-2020 for the purpose of Annual General Meeting.
April 09, 2018 DrDisc. under Reg.30 of SEBI (SAST) Reg.2011r. Murali K. Divi has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 29, 2020 August 08, 2020 Financial Results To consider and approve the financial results for the period ended Jun 30, 2020
June 01, 2020 June 06, 2020 Financial Results To consider and approve the financial results for the period ended March 31, 2020
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play